Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-03-23 Purchase |
2021-03-24 7:21 pm |
Sio Gene Therapies Inc. | SIOX | Cheruvu Pavan Chief Executive Officer |
100,000 | $2.4818 | $248,180 | 180,426 (Direct) |
View |
| 2020-11-24 Purchase |
2020-11-25 9:07 pm |
Sio Gene Therapies Inc. | SIOX | Pande Atul Director |
10,000 | $2.3399 | $23,399 | 33,370 (Indirect) |
View |
| 2020-07-08 Purchase |
2020-07-10 6:12 pm |
Axovant Gene Therapies Ltd. | AXGT | Pande Atul Director |
10,000 | $2.729 | $27,290 | 23,370 (Indirect) |
View |
| 2020-07-08 Purchase |
2020-07-10 6:11 pm |
Axovant Gene Therapies Ltd. | AXGT | Cheruvu Pavan Principal Executive Officer |
37,500 | $2.737 | $102,638 | 57,836 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-02-08 Option Award |
2022-02-10 5:07 pm |
N/A N/A |
Sio Gene Therapies Inc. | SIOX | Meswani Parag V Chief Commercial Officer |
153,700 | $0 | 153,700 (Direct) |
View |
| 2022-02-08 Option Award |
2022-02-10 5:05 pm |
N/A N/A |
Sio Gene Therapies Inc. | SIOX | Nassif David W. Interim CEO, CFO |
546,500 | $0 | 546,500 (Direct) |
View |
Ownership |
2022-02-07 7:17 pm |
N/A N/A |
Sio Gene Therapies Inc. | SIOX | Meswani Parag V Chief Commercial Officer |
0 | $0 | 368,799 (Direct) |
View |
| 2021-12-08 Option Award |
2021-12-09 6:31 pm |
N/A N/A |
Sio Gene Therapies Inc. | SIOX | Nassif David W. Chief Financial Officer |
17,534 | $0 | 80,310 (Direct) |
View |
| 2021-12-08 Tax Withholding |
2021-12-09 6:31 pm |
N/A N/A |
Sio Gene Therapies Inc. | SIOX | Nassif David W. Chief Financial Officer |
6,294 | $1.42 | 80,310 (Direct) |
View |
| 2021-12-08 Option Award |
2021-12-09 6:31 pm |
N/A N/A |
Sio Gene Therapies Inc. | SIOX | Cheruvu Pavan Chief Executive Officer |
37,567 | $0 | 278,242 (Direct) |
View |
| 2021-12-08 Tax Withholding |
2021-12-09 6:31 pm |
N/A N/A |
Sio Gene Therapies Inc. | SIOX | Cheruvu Pavan Chief Executive Officer |
14,884 | $1.42 | 278,242 (Direct) |
View |
| 2021-04-15 Option Award |
2021-04-19 4:59 pm |
N/A 2031-04-14 |
Sio Gene Therapies Inc. | SIOX | Vuori Kristiina MD Director |
42,000 | $0 | 42,000 (Direct) |
View |
| 2021-04-15 Option Award |
2021-04-19 4:57 pm |
N/A 2031-04-14 |
Sio Gene Therapies Inc. | SIOX | Torti Frank Director |
42,000 | $0 | 42,000 (Direct) |
View |
| 2021-04-15 Option Award |
2021-04-19 4:56 pm |
N/A 2031-04-14 |
Sio Gene Therapies Inc. | SIOX | Sundaram Senthil Vel Director |
42,000 | $0 | 42,000 (Direct) |
View |
| 2021-04-15 Option Award |
2021-04-19 4:55 pm |
N/A 2031-04-14 |
Sio Gene Therapies Inc. | SIOX | Pande Atul Director |
42,000 | $0 | 42,000 (Direct) |
View |
| 2021-04-15 Option Award |
2021-04-19 4:54 pm |
N/A 2031-04-14 |
Sio Gene Therapies Inc. | SIOX | Modig Berndt Director |
42,000 | $0 | 42,000 (Direct) |
View |
| 2021-04-15 Option Award |
2021-04-19 4:53 pm |
N/A 2031-04-14 |
Sio Gene Therapies Inc. | SIOX | Nassif David W. Chief Financial Officer |
239,000 | $0 | 239,000 (Direct) |
View |
| 2021-04-15 Option Award |
2021-04-19 4:52 pm |
N/A 2031-04-14 |
Sio Gene Therapies Inc. | SIOX | Corcoran Gavin Chief R&D Officer |
244,300 | $0 | 244,300 (Direct) |
View |
| 2021-04-15 Option Award |
2021-04-19 4:51 pm |
N/A 2031-04-14 |
Sio Gene Therapies Inc. | SIOX | Cheruvu Pavan Chief Executive Officer |
682,100 | $0 | 682,100 (Direct) |
View |
| 2021-03-22 Option Award |
2021-03-22 9:25 pm |
N/A N/A |
Sio Gene Therapies Inc. | SIOX | Nassif David W. Chief Financial Officer |
15,060 | $0 | 34,004 (Direct) |
View |
| 2021-03-17 Option Award |
2021-03-19 4:58 pm |
N/A N/A |
Sio Gene Therapies Inc. | SIOX | Corcoran Gavin Chief R&D Officer |
16,001 | $0 | 25,792 (Direct) |
View |
| 2021-03-17 Option Award |
2021-03-19 4:55 pm |
N/A N/A |
Sio Gene Therapies Inc. | SIOX | Cheruvu Pavan Chief Executive Officer |
22,590 | $0 | 80,426 (Direct) |
View |
| 2020-10-05 Option Award |
2020-10-07 9:28 pm |
N/A 2030-10-04 |
Axovant Gene Therapies Ltd. | AXGT | Vuori Kristiina MD Director |
35,000 | $0 | 35,000 (Direct) |
View |
| 2020-06-11 Tax Withholding |
2020-06-15 7:40 pm |
N/A N/A |
Axovant Gene Therapies Ltd. | AXGT | Nassif David W. Principal Financial Officer |
5,266 | $3.25 | 34,004 (Direct) |
View |
| 2020-06-11 Option Award |
2020-06-15 7:40 pm |
N/A N/A |
Axovant Gene Therapies Ltd. | AXGT | Nassif David W. Principal Financial Officer |
15,060 | $0 | 34,004 (Direct) |
View |
| 2020-06-11 Tax Withholding |
2020-06-15 7:39 pm |
N/A N/A |
Axovant Gene Therapies Ltd. | AXGT | Cheruvu Pavan Principal Executive Officer |
9,755 | $3.09 | 42,926 (Direct) |
View |
| 2020-06-11 Option Award |
2020-06-15 7:39 pm |
N/A N/A |
Axovant Gene Therapies Ltd. | AXGT | Cheruvu Pavan Principal Executive Officer |
22,591 | $0 | 42,926 (Direct) |
View |
| 2020-06-12 Tax Withholding |
2020-06-15 7:38 pm |
N/A N/A |
Axovant Gene Therapies Ltd. | AXGT | Corcoran Gavin Chief R&D Officer |
6,211 | $3.46 | 25,792 (Direct) |
View |
| 2020-06-12 Option Award |
2020-06-15 7:38 pm |
N/A N/A |
Axovant Gene Therapies Ltd. | AXGT | Corcoran Gavin Chief R&D Officer |
16,002 | $0 | 25,792 (Direct) |
View |